期刊文献+

加替沙星滴眼液无菌检查方法的建立 被引量:4

Sterility test method for gatifloxacin eye drops
暂未订购
导出
摘要 目的:建立加替沙星滴眼液无菌检查方法。方法:参照《中国药典》2005版方法进行试验。结果:采用薄膜过滤法,以0.1%蛋白胨,0.1%吐温-80水溶液作为冲洗液,选择冲洗量为每滤筒800 ml,并以0.1 mol/L硫酸锰为中和剂,即可消除样品对各菌株的抗菌活性。结论:加替沙星滴眼液可按此方法进行无菌检查。 Objective: To establish a sterility test method for gatifioxacin eye drops. Methods: A test method was set up and improved on the basis of the official one of Chinese Pharmacopoeia( edited in 2005 ). Results: Antibacterial activity of gatifolxacin could be eliminated by membrane filtration method in which a water solution of 0.1% peptone and 0.1% of Tween was used as a rinse solution. The volume of the rinse solution was 800 m1,0.1 mol/L of manganese sulfate solution was used for neutralization. Conclusion: The method established in the paper is valid in sterility test for gatifloxacin eye drops.
出处 《天津药学》 2009年第4期7-9,共3页 Tianjin Pharmacy
关键词 加替沙星滴眼液 中和剂 冲洗液 无菌检查法 gatifloxacin eye drops, neutralization, rinse solution, sterility test
  • 相关文献

参考文献2

二级参考文献10

共引文献57

同被引文献26

  • 1马仕洪,刘鹏,戴翚,特玉香,胡昌勤.加替沙星无菌检查方法的建立与标准操作探讨[J].药物分析杂志,2007,27(6):877-880. 被引量:20
  • 2国家药典委员会.中国药典2010年版[M].北京:化学工业出版社.2010.
  • 3陈新谦,金有豫,汤光,等.新编药物学[M].17版.北京:人民卫生出版社,2010:384.
  • 4Schultz, C. Gatifloxacin ophthalmic solution for treatment of bacterialconjunctivitis: safety, efficacy and patient perspective [J]. OphthalmolEye Dis, 2012, 4:65-70.
  • 5Yadav, V, Sultana, S,Yadav,J, et al. Gatifloxacin induces S andG2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PLoS One, 2012,7(10): e47796-e47796 .
  • 6Gomez, C, Ponien, P, Serradji, N, et al. Synthesis of gatifloxacinderivatives and their biological activities against Mycobacteriumleprae and Mycobacterium tuberculosis [J]. Bioorg Med Chem, 2012,21(4): 948-956.
  • 7Facchinetti V,Gomes CR, de Souza MV, et al. Perspectives on thedevelopment of novel potentially active quinolones againsttuberculosis and cancer[J]. Mini Rev Med Chem, 2012, 12(9):866-874.
  • 8Tascini C, Leonildi A, Ciullo I,et al. Susceptibility of Streptococcuspneumoniae clinical isolates to quinolones[J]. J Chemothera, 2012,24(3):185-186.
  • 9Deutschendorf C, Goldani LZ, Santos RP. Previous use of quinolones:a surrogate marker for first line anti-tuberculosis drugs resistance inHIV-infected patients[J]. Braz J Infect Dis, 2012,16(2): 142-145.
  • 10尤启东.药物化学[M].北京:化学工业出版社,2005:418.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部